Efficacy and safety of cefepime in pediatric patients: A systematic review and meta-analysis

Journal of Pediatrics

Volumn 157, Issue 3, 2010, Pages

  Adderson, Elisabeth E ^a,b   Flynn, Patricia M ^a,b   Hoffman, James M ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Absolute neutrophil count; ANC; FDA; RD; Risk difference; Risk ratio; RR; United States Food and Drug Administration; Urinary tract infection; UTI; VAP; Ventilator associated pneumonia

Indexed keywords

AMIKACIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; MEROPENEM; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CLINICAL TRIAL; COCHRANE LIBRARY; DRUG EFFICACY; DRUG SAFETY; EMBASE; FEBRILE NEUTROPENIA; HUMAN; MEDLINE; MENINGITIS; META ANALYSIS; METHODOLOGY; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA; CHILD; COMPARATIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; CHILD; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84923652429     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2010.03.023     Document Type: Article

References (30)

1. G.P. Bodey, D.H. Ho, and B. LeBlanc In vitro studies of BMY-28142, a new broad-spectrum cephalosporin Antimicrob Agents Chemother 27 1985 265 269
2. Elan Biopharmaceuticals. Maxipime (cefepime hydrochloride) for Injection - prescribing information. (Revised March 2009.) Available at: http://www.elan.com/therapies/products/default.asp. Accessed Sep 30, 2009
3. C.C. Sanders Cefepime: the next generation? Clin Infect Dis 17 1993 369 379
4. M. Paul, D. Yahav, A. Fraser, and L. Leibovici Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials J Antimicrob Chemother 57 2006 176 189
5. D. Yahav, M. Paul, A. Fraser, N. Sarid, and L. Leibovici Efficacy and safety of cefepime: a systematic review and meta-analysis Lancet Infect Dis 7 2007 338 348
6. United States Food and Drug Administration. Early communication about an ongoing safety review:cefepime (marketed as Maxipime). (Updated 06/18/2009.) Available at: www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHeathcareProfessionals/ucm070496.htm. Accessed Sep 30, 2009.
7. United States Food and Drug Administration. Cefepime (marketed as Maxipime) Update of Ongoing Safety Review. (Updated 06/17/2009.) Available at: www.fda.gov/Safety/MedWatch/SafetyInformation/ SafetyAlertsforHumanMedicalProducts/ucm167427.htm. Accessed Sep 30, 2009.
8. A.R. Jadad, R.A. Moore, D. Carroll, C. Jenkinson, D.J. Reynolds, and D.J. Gavaghan Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1996 1 12
9. A.P. Verhagen, H.C. de Vet, R.A. de Bie, A.G. Kessels, M. Boers, and L.M. Bouter The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus J Clin Epidemiol 51 1998 1235 1241
10. The Cochrane Information Management System. Review Manager (RevMan) 5.0.15 ed. Available at: www.cc-ims.net. Accessed Sep 30, 2009.
11. Gulsun BS, Canpolat C, Cebecci D. Cefepim and ceftazidime in conbination with amikasin in febrile neutropenia of childhood: which regimen is more effective? In: Joint Congress of the 6th TRANSMED Pediatric and 34th Turkish Pediatric Association Congress. Istanbul; 1998.
12. J.S. Bradley, and A. Arrieta Empiric use of cefepime in the treatment of lower respiratory tract infections in children Pediatr Infect Dis J 20 2001 343 349
13. Food and Drug Administration Center for Drug Evaluation and Research. Medical officer review of pediatric use supplement NDA 50-679/SLR-007. Available at: www.fda.gov/Cder/foi/nda/99/50679S007-Maxipine-medr.pdf. Accessed Dec 7, 2008.
14. L. Agaoglu, O. Devecioglu, S. Anak, Z. Karakas, N. Yalman, and B. Biner Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey J Chemother 13 2001 281 287
15. Y.Y. Chuang, I.J. Hung, C.P. Yang, T.H. Jaing, T.Y. Lin, and Y.C. Huang Cefepime versus ceftazidime as empiric monotherapy for fever and neutropenia in children with cancer Pediatr Infect Dis J 21 2002 203 209
16. F. Corapcioglu, and N. Sarper Cefepime versus ceftazidime + amikacin as empirical therapy for febrile neutropenia in children with cancer: a prospective randomized trial of the treatment efficacy and cost Pediatr Hematol Oncol 22 2005 59 70
17. F. Corapcioglu, N. Sarper, and E. Zengin Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison Pediatr Hematol Oncol 23 2006 177 186
18. R. Kebudi, O. Gorgun, I. Ayan, N. Gurler, F. Akici, and K. Toreci Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors Med Pediatr Oncol 36 2001 434 441
19. T. Kutluk, O. Kurne, C. Akyuz, M. Ceyhan, G. Kanra, and M. Buyukpamukcu Cefepime vs meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours Pediatr Blood Cancer 42 2004 284 286
20. M.M. Mustafa, L. Carlson, I. Tkaczewski, G.H. McCracken Jr., and G.R. Buchanan Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia Pediatr Infect Dis J 20 2001 362 369
21. A. Oguz, C. Karadeniz, E.C. Citak, V. Cil, and N. Eldes Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors Pediatr Hematol Oncol 23 2006 245 253
22. J.J. Huang, Q. Zeng, and J.L. Yu [Therapeutic effects of cefepime and sulbactam/cefoperazone on moderate and severe respiratory tract infection in children] (in Chinese) Di Yi Jun Yi Da Xue Xue Bao 25 2005 1199 1200
23. S.K. Shahid Efficacy and safety of cefepime in late-onset ventilator-associated pneumonia in infants: a pilot randomized and controlled study Ann Trop Med Parasitol 102 2008 63 71
24. A.C. Arrieta, and J.S. Bradley Empiric use of cefepime in the treatment of serious urinary tract infections in children Pediatr Infect Dis J 20 2001 350 355
25. X. Saez-Llorens, and M. O'Ryan Cefepime in the empiric treatment of meningitis in children Pediatr Infect Dis J 20 2001 356 361
26. U.B. Schaad, J. Eskola, D. Kafetzis, M. Fishbach, S. Ashkenazi, and V. Syriopoulou Cefepine vs ceftazidime treatment of pyelonephritis: a European, randomized, controlled study of 300 pediatric cases. European Society for Paediatric Infectious Diseases (ESPID) Pyelonephritis Study Group Pediatr Infect Dis J 17 1998 639 644
27. L.L. Kjaergard, J. Villumsen, and C. Gluud Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses Ann Intern Med 135 2001 982 989
28. R.P. Dellinger, M.M. Levy, J.M. Carlet, J. Bion, M.M. Parker, and R. Jaeschke Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 Intensive Care Med 34 2008 17 60
29. K.V. Rolston The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: salient features and comments Clin Infect Dis 39 Suppl. 1 2004 S44 S48
30. T.D. Nguyen, B. Williams, and E. Trang Cefepime therapy and all-cause mortality Clin Infect Dis 2009